tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Suji Jeong, 6 are a HOLD (42.86%), 8 are a BUY (57.14%).
Analyst Suji Jeong, carries an average stock price target met ratio of 40% that have a potential upside of 38.77% achieved within 194 days. Previously, Suji Jeong worked at JEFFERIES.
Suji Jeong’s has documented 28 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VRNA, Verona Pharma PLC ADR at 09-Jul-2025.
Analyst best performing recommendations are on INZY (INOZYME PHARMA ).
The best stock recommendation documented was for INZY (INOZYME PHARMA ) at 3/23/2023. The price target of $6 was fulfilled within 26 days with a profit of $2.7 (81.82%) receiving and performance score of 31.47.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 19-Apr-2023
$14.75
$0.01 (0.07%)
$14.75
2 years 7 months 30 days ago
(15-May-2023)
4/7 (57.14%)
$0.28 (1.94%)
170
Hold
Since 19-Apr-2023
$14.75
$0.01 (0.07%)
$21
2 years 8 months 26 days ago
(19-Apr-2023)
2/4 (50%)
$0.31 (2.15%)
253
Hold
Since 18-Apr-2023
$14.75
$0.01 (0.07%)
$20
2 years 8 months 27 days ago
(18-Apr-2023)
2/3 (66.67%)
$0.31 (2.15%)
349
Hold
Since 18-Apr-2023
$14.75
$0.01 (0.07%)
$15
2 years 8 months 27 days ago
(18-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
69
Buy
Since 26-Jun-2020
$20
$5.26 (35.69%)
$20
2 years 9 months 23 days ago
(22-Mar-2023)
3/7 (42.86%)
$12.23 (157.40%)
615
What Year was the first public recommendation made by Suji Jeong?
